Preventive and/or therapeutic agent for viral infection

Abstract

Provided is a novel preventive and / or therapeutic agent against a virus, disclosed is a preventive and / or therapeutic agent against a viral infection containing geranyl-geranyl acetone as an active ingredient. Also, disclosed are inducers for increasing the activity of an anitiviral factor and for protein kinase containing geranyl-geranyl acetone as an active ingredient. Moreover, a method for preventing and / or treating a viral infection which contains administering a patient a effective amount of an agent containing geranyl-geranyl acetone as an active ingredient.

Description

Technical field [0001] The present invention relates to a new use of teprenone (geranylgeranylacetone) as a preventive and therapeutic agent, and more specifically, to a preventive and therapeutic agent for viral infections containing teprenone as an active ingredient. Background technique [0002] Viruses are the cause of various diseases. For example, influenza A virus infection causes group infections or pandemics worldwide. It is one of the viruses that often causes severe symptoms in young children, the elderly, heart and lung diseases or immunodeficiency patients (see Non Patent documents 1-3). [0003] In recent years, although various treatment methods are constantly improving, no effective treatment method for the virus has yet been found. At present, although vaccination with inactivated vaccines is used as the most effective method, for example, influenza A virus cleverly changes its surface antigenicity, which often leads to a reduction in the therapeutic effect of th...

AI Technical Summary

Problems solved by technology

[0008] However, the HSP induction method requires heat shock, sodium arsenite, heavy metals and other environmental stressors, or pathological stressors such as ischemia, so it is not practical in clinical application, and HSPs that are safe for living organisms have not yet been established. Induction method

Images